Abeona Therapeutics

+$0.0011 (+0.60%) Today
+$0.003 (+1.63%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABEO and other ETFs, options, and stocks.

About ABEO

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB).

CEO
Vishwas Seshadri
Employees
90
Headquarters
New York, New York
Founded
1974

ABEO Key Statistics

Market cap
27.53M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.98M
High today
$0.2037
Low today
$0.1755
Open price
$0.1755
Volume
2.82M
52 Week high
$1.70
52 Week low
$0.1303

ABEO Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 27, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure